434 related articles for article (PubMed ID: 15213268)
1. Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.
Graciano ML; Cavaglieri Rde C; Dellê H; Dominguez WV; Casarini DE; Malheiros DM; Noronha IL
J Am Soc Nephrol; 2004 Jul; 15(7):1805-15. PubMed ID: 15213268
[TBL] [Abstract][Full Text] [Related]
2. Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
Schricker K; Hegyi I; Hamann M; Kaissling B; Kurtz A
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8006-10. PubMed ID: 7644529
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
4. Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade.
Kasper SO; Basso N; Kurnjek ML; Paglia N; Ferrario CM; Ferder LF; Diz DI
Am J Nephrol; 2005; 25(4):335-41. PubMed ID: 15976496
[TBL] [Abstract][Full Text] [Related]
5. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhibition and renal alterations.
Jover B; Mimran A
J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S65-70. PubMed ID: 11811381
[TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Zappellini A; Teixeira SA; Muscará MN; Zatz R; Antunes E; De Nucci G
Eur J Pharmacol; 1996 Dec; 317(2-3):285-91. PubMed ID: 8997612
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt.
Richer-Giudicelli C; Domergue V; Gonzalez MF; Messadi E; Azizi M; Giudicelli JF; Ménard J
J Hypertens; 2004 Mar; 22(3):619-27. PubMed ID: 15076169
[TBL] [Abstract][Full Text] [Related]
9. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
10. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
Ots M; Mackenzie HS; Troy JL; Rennke HG; Brenner BM
J Am Soc Nephrol; 1998 Feb; 9(2):224-30. PubMed ID: 9527398
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
Mervaala E; Dehmel B; Gross V; Lippoldt A; Bohlender J; Milia AF; Ganten D; Luft FC
J Am Soc Nephrol; 1999 Aug; 10(8):1669-80. PubMed ID: 10446934
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
Morrissey JJ; Ishidoya S; McCracken R; Klahr S
J Am Soc Nephrol; 1996 Oct; 7(10):2202-12. PubMed ID: 8915981
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
15. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of nitric oxide on the renin-angiotensin system in Dahl salt-sensitive rats.
Kasuya A; Satoh S; Yoshida M; Hisa H; Suzuki-Kusaba M; Satoh S
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):914-9. PubMed ID: 10561814
[TBL] [Abstract][Full Text] [Related]
17. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
Richer C; Bruneval P; Ménard J; Giudicelli JF
Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242
[TBL] [Abstract][Full Text] [Related]
18. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
D'Amours M; Lebel M; Grose JH; Larivière R
Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
[TBL] [Abstract][Full Text] [Related]
19. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.
Gwathmey TM; Westwood BM; Pirro NT; Tang L; Rose JC; Diz DI; Chappell MC
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F983-90. PubMed ID: 20810609
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Uhlenius N; Miettinen A; Vuolteenaho O; Tikkanen I
Kidney Blood Press Res; 2002; 25(2):71-9. PubMed ID: 12077487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
